nisha

Reported Uses

• NOTE: see Herb & Supplement Effectiveness Rating Definitions table
• acne [Insufficient Evidence]
• acral erythema, chemo-induced [Insufficient Evidence]
• allergic rhinitis [Possibly Effective]
• Alzheimer dz [Possibly Ineffective]
• amenorrhea [Insufficient Evidence]
• ankylosing spondylitis [Insufficient Evidence]
• aphthous ulcer (canker sores) [Insufficient Evidence]
• arthralgia, aromatase inhibitor-induced [Insufficient Evidence]
• asthma [Insufficient Evidence]
• athletic performance [Insufficient Evidence]
• beta-thalassemia [Insufficient Evidence]
• BPH [Insufficient Evidence]
• bruising [Insufficient Evidence]
• CABG [Insufficient Evidence]
• cachexia [Insufficient Evidence]
• carpal tunnel syndrome [Insufficient Evidence]
• CKD [Insufficient Evidence]
• cognitive decline, age-related [Insufficient Evidence]
• colorectal adenoma [Insufficient Evidence]
• colorectal CA [Insufficient Evidence]
• constipation, chemo-induced [Insufficient Evidence]
• COVID-19 [Insufficient Evidence]
• Crohn dz [Insufficient Evidence]
• denture stomatitis [Insufficient Evidence]
• depression [Possibly Effective]
• diabetes mellitus [Insufficient Evidence]
• diabetic foot ulcer [Insufficient Evidence]
• diabetic nephropathy [Insufficient Evidence]
• diarrhea, chemo-induced [Insufficient Evidence]
• dysmenorrhea [Insufficient Evidence]
• dyspepsia [Possibly Effective]
• endometriosis [Insufficient Evidence]
• erythema [Insufficient Evidence]
• exercise-induced muscle soreness [Insufficient Evidence]
• gingivitis [Insufficient Evidence]
• gout [Insufficient Evidence]
• Gulf war syndrome [Insufficient Evidence]
• H. pylori infection [Insufficient Evidence]
• HTN [Insufficient Evidence]
• hyperlipidemia [Possibly Effective]
• IBS [Insufficient Evidence]
• impaired glucose tolerance [Insufficient Evidence]
• joint pain [Insufficient Evidence]
• juvenile idiopathic arthritis [Insufficient Evidence]
• knee pain [Insufficient Evidence]
• lichen planus [Insufficient Evidence]
• metabolic syndrome [Insufficient Evidence]
• MI [Insufficient Evidence]
• migraine prophylaxis [Insufficient Evidence]
• nausea/vomiting, chemo-induced [Insufficient Evidence]
• nonalcoholic fatty liver dz [Possibly Effective]
• obesity [Insufficient Evidence]
• oral mucositis, chemo- or XRT-related [Possibly Effective]
• oral submucous fibrosis [Insufficient Evidence]
• osteoarthritis [Possibly Effective]
• pain, acute [Insufficient Evidence]
• peptic ulcer [Possibly Ineffective]
• periodontitis [Insufficient Evidence]
• peripheral neuropathy, chemo-induced [Insufficient Evidence]
• physical performance [Insufficient Evidence]
• polycystic ovary syndrome [Insufficient Evidence]
• postop pain [Insufficient Evidence]
• premenstrual syndrome [Insufficient Evidence]
• prostate CA [Insufficient Evidence]
• pruritus [Possibly Effective]
• psoriasis [Insufficient Evidence]
• quality of life [Insufficient Evidence]
• radiation dermatitis [Insufficient Evidence]
• radiation proctopathy [Insufficient Evidence]
• respiratory infections [Insufficient Evidence]
• rheumatoid arthritis [Insufficient Evidence]
• sarcopenia [Insufficient Evidence]
• schizophrenia [Insufficient Evidence]
• sepsis [Insufficient Evidence]
• SLE [Insufficient Evidence]
• smoking cessation [Insufficient Evidence]
• stress [Insufficient Evidence]
• stroke [Insufficient Evidence]
• tuberculosis [Insufficient Evidence]
• ulcerative colitis [Insufficient Evidence]
• uveitis [Insufficient Evidence]
• wound healing [Insufficient Evidence]